"Latent Tuberculosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The dormant form of TUBERCULOSIS where the person shows no obvious symptoms and no sign of the causative agent (Mycobacterium tuberculosis) in the SPUTUM despite being positive for tuberculosis infection skin test.
| Descriptor ID |
D055985
|
| MeSH Number(s) |
C01.252.410.040.552.846.122
|
| Concept/Terms |
Latent Tuberculosis- Latent Tuberculosis
- Latent Tuberculoses
- Tuberculoses, Latent
- Tuberculosis, Latent
- Latent Tuberculosis Infection
- Infection, Latent Tuberculosis
- Infections, Latent Tuberculosis
- Latent Tuberculosis Infections
- Tuberculosis Infection, Latent
- Tuberculosis Infections, Latent
|
Below are MeSH descriptors whose meaning is more general than "Latent Tuberculosis".
Below are MeSH descriptors whose meaning is more specific than "Latent Tuberculosis".
This graph shows the total number of publications written about "Latent Tuberculosis" by people in this website by year, and whether "Latent Tuberculosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 1 | 2 |
| 2012 | 1 | 1 | 2 |
| 2013 | 0 | 1 | 1 |
| 2015 | 4 | 1 | 5 |
| 2016 | 5 | 0 | 5 |
| 2017 | 34 | 11 | 45 |
| 2018 | 49 | 11 | 60 |
| 2019 | 22 | 3 | 25 |
| 2020 | 4 | 0 | 4 |
| 2021 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Latent Tuberculosis" by people in Profiles.
-
Elevated Rates of Indeterminate Results on QuantiFERON-TB Gold Plus in COVID-19 Patients. J Clin Microbiol. 2021 09 20; 59(10):e0141421.
-
Latent tuberculosis co-infection is associated with heightened levels of humoral, cytokine and acute phase responses in seropositive SARS-CoV-2 infection. J Infect. 2021 09; 83(3):339-346.
-
Indeterminate QuantiFERON Gold Plus Results Reveal Deficient Interferon Gamma Responses in Severely Ill COVID-19 Patients. J Clin Microbiol. 2021 09 20; 59(10):e0081121.
-
[Friend or Foe? Evaluation of BCG Vaccine and Latent Tuberculosis Infection Effect in Patients Diagnosed with COVID-19 Infection]. Mikrobiyol Bul. 2021 Jul; 55(3):300-310.
-
Preventing Infectious Complications of Immunomodulation in COVID-19 in Foreign-Born Patients. J Immigr Minor Health. 2021 Dec; 23(6):1343-1347.
-
COVID-19 and TB: a progression-regression conundrum. Int J Tuberc Lung Dis. 2021 06 01; 25(6):421-423.
-
Biologic Treatment Algorithms for Moderate-to-Severe Psoriasis with Comorbid Conditions and Special Populations: A Review. Am J Clin Dermatol. 2021 Jul; 22(4):425-442.
-
Preliminary observations on IGRA testing for TB infection in patients with severe COVID-19 eligible for immunosuppressive therapy. Respir Med. 2020 12; 175:106204.
-
Role of latent tuberculosis infections in reduced COVID-19 mortality: Evidence from an instrumental variable method analysis. Med Hypotheses. 2020 Nov; 144:110214.
-
Infantile spasms and COVID-19: Challenges and solutions in resource-limited settings. Epilepsy Res. 2020 11; 167:106441.